Wells Fargo’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $901K | Buy |
34,655
+508
| +1% | +$13.2K | ﹤0.01% | 3419 |
|
|
2025
Q1 | $836K | Buy |
34,147
+5,913
| +21% | +$145K | ﹤0.01% | 3369 |
|
|
2024
Q4 | $810K | Buy |
28,234
+8,803
| +45% | +$252K | ﹤0.01% | 3410 |
|
|
2024
Q3 | $733K | Buy |
19,431
+8,885
| +84% | +$335K | ﹤0.01% | 3397 |
|
|
2024
Q2 | $333K | Buy |
10,546
+923
| +10% | +$29.1K | ﹤0.01% | 3827 |
|
|
2024
Q1 | $422K | Buy |
+9,623
| New | +$422K | ﹤0.01% | 3657 |
|